Company overview
Spectral Instruments Imaging manufactures advanced preclinical in-vivo optical imaging systems for bioluminescence, fluorescence, and X-ray imaging used in disease research and drug development. The company provides co-registered multi-modality imaging platforms with high-sensitivity detection capabilities, field-upgradable options, and integrated software solutions for small animal models and cell-based assays. Founded in 2009 and acquired by Bruker Corporation in 2024, SII serves pharmaceutical and biomedical research organizations requiring quantitative 3D optical imaging for preclinical studies.
Preclinical Optical Imaging Systems is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include preclinical imaging, bioluminescence imaging, fluorescence imaging, in-vivo optical imaging, small animal imaging.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://spectralinvivo.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- preclinical imaging, bioluminescence imaging, fluorescence imaging, in-vivo optical imaging, small animal imaging
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What imaging modalities does Spectral Instruments Imaging offer?
- Spectral Instruments Imaging provides bioluminescence imaging (BLI), fluorescence imaging (FLI), and X-ray imaging capabilities. Their systems feature co-registered multi-modality imaging, allowing researchers to combine multiple imaging techniques in a single platform for comprehensive preclinical analysis.
- What are the key technical specifications of SII imaging systems?
- SII systems are engineered with advanced optics, patented illumination technology, and -90°C air-cooled high-sensitivity cameras. The systems provide absolute calibration, quantitative 3D optical imaging, and unmatched bioluminescent and fluorescent imaging sensitivity for reliable preclinical results.
- Which animal models and research applications are supported?
- Spectral Instruments Imaging systems are designed for small animal models and cell-based assays used in preclinical research. Their platforms support disease research applications and are integrated with imaging software such as Aura 4.0 for enhanced data analysis and visualization.
- Are SII systems field-upgradable?
- Yes, Spectral Instruments Imaging systems feature robust, field-upgradable options that provide researchers with flexibility to expand their imaging capabilities as research needs evolve, including the ability to add X-ray imaging functionality.
- What software solutions are available with SII systems?
- Spectral Instruments Imaging systems integrate with advanced imaging software such as Aura Imaging Software 4.0, which features Smart Exposure technology to capture both faint and strong signals in single images, streamlining the imaging process and enhancing data accuracy.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
